The transcription factor Fos: a Janus-type regulator in health and disease.
Open accessThe DOI matches its OpenAlex record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The immediate early gene product Fos is part of the activator protein-1 (AP-1) transcription factor and has been shown to participate in the molecular mechanisms of cell proliferation, differentiation, apoptosis, and transformation. The analysis of genetically modified mice and cells derived thereof has provided important new insights into its specific biological functions in development, tissue homeostasis, and cellular responses to environmental insults. Moreover, the deregulation of Fos could be linked with a variety of pathological conditions, including immunological, skeletal and neurological defects, as well as oncogenic transformation and tumor progression. In contrast to the mainstream opinion concerning the oncogenic function of Fos an increasing number of experimental reports also describe a tumor-suppressive function in various cancer types. More recently, altered Fos expression in cell culture and mouse models combined with global gene expression analysis unraveled novel downstream effectors of the Fos-regulated genetic program. Finally, selective inhibition of its function with a small molecule inhibitor in a preclinical mouse model of arthritis demonstrated that targeting Fos/AP-1 activity could be an auspicious new option for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 2×
“The Fos gene is subjected to complex regulation at multiple interwoven transcriptional and posttranscriptional levels, which is necessary to avoid, or at least limit, pathological effects caused by its deregulation (Shaulian and Karin, 2002; Lee et al., 2006).”
BackgroundTakayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701 · cited 2×
“Fosl1, which encodes the Fos family member Fra1, and the nuclear factor of activated T cells c1 (Nfatc1) have been identified as direct Fos target genes in osteoclasts (Takayanagi et al., 2002).”
BackgroundExpression of c- fos Protein in Brain: Metabolic Mapping at the Cellular Level
Sagar, S. M., Sharp, F. R., & Curran, T. (1988) · Science · doi:10.1126/science.3131879 · Cited by 1,925
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Measurement of Immediate‐Early Gene Activation‐ c‐fos and Beyond
Kovács, K. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01734.x · Cited by 493
The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development
Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J., & Wagner, E. F. (2000) · Cell · doi:10.1016/s0092-8674(00)00026-x · Cited by 304 · cited 1×
“More recently, we analyzed skin tumor samples from control and Fos∆ep mice that developed due to ectopic expression of a constitutive active mutant of human son of sevenless (SOS-F), a potent upstream activator of oncogenic Ras, in keratinocytes (Sibilia et al., 2000).”
BackgroundOkada, S., Wang, Z.-Q., Grigoriadis, A. E., Wagner, E. F., & von Rüden, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.382-390.1994 · Cited by 62
Cited by
Trop2 and its overexpression in cancers: regulation and clinical/ therapeutic implications
Shvartsur, A., & Bonavida, B. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.40 · Cited by 410
A Brief Introduction to the Transduction of Neural Activity into Fos Signal
Chung, L. (2015) · Development & Reproduction · doi:10.12717/dr.2015.19.2.061 · Cited by 164
“First, in repeated stimuli presentation over multiple days, what does the Fos signal represent? How can we separate the Fos change itself from experimental main effect? Second, beyond the role of activity marker, what is the inherent role of Fos in behaving animals (Zhang et al., 2002; Durchdewald et al., 2009)? What…”
BackgroundProjection neurons of the vestibulo‐sympathetic reflex pathway
Holstein, G. R., Friedrich, V. L., & Martinelli, G. P. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23517 · Cited by 71
de Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00240 · Cited by 44
“C-fos: The Prototypical IEG C-fos Regulation by Dopamine C-fos is a proto-oncogene encoding for a TF that is induced in response to multiple stimuli, included neural activity (Durchdewald et al., 2009).”
Background
Metadata
- Authors
- Durchdewald, M., Angel, P. E., & Heß, J.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2009-11-01
- Volume
- 24
- Issue
- 11
- Pages
- 1451-61
- OpenAlex
- W2142701968
- Cited by
- 124
- References
- 7
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The transcription factor Fos: a Janus-type regulator in health and disease. https://app.cochat.ai/papers/10.14670/hh-24.1451
- The paper
- Durchdewald, M., Angel, P. E., & Heß, J. (2009). The transcription factor Fos: a Janus-type regulator in health and disease. PubMed. https://doi.org/10.14670/hh-24.1451
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.